Degree of patient-reported qualitative improvement after initial treatment; cells without sample sizes denote results obtained from all patients in the given cohort
| TM | AFM | AFM subtypes | ||
| Grey matter | Mixed matter | |||
| N | 39 | 51 | 23 | 21 |
| Corticosteroids | 35 (90%) | 35 (69%) | 13 (57%) | 19 (90%) |
| No improvement | 8 (24%), n=34 | 12 (34%) | 4 (31%) | 7 (37%) |
| Minimal improvement | 12 (35%), n=34 | 13 (37%) | 4 (31%) | 8 (42%) |
| Some improvement | 9 (26%), n=34 | 5 (14%) | 2 (15%) | 2 (11%) |
| Mostly recovered | 5 (15%), n=34 | 4 (11%) | 3 (23%) | 1 (5%) |
| Fully recovered | 0, n=34 | 1 (3%) | 0 | 1 (5%) |
| IVIG | 3 (8%) | 15 (29%) | 10 (43%) | 2 (10%) |
| No improvement | 1 (50%), n=2 | 6 (40%) | 5 (50%) | 1 (50%) |
| Minimal improvement | 1 (50%), n=2 | 4 (27%) | 2 (20%) | 1 (50%) |
| Some improvement | 0 | 3 (20%) | 2 (20%) | 0 |
| Mostly recovered | 0 | 2 (13%) | 1 (10%) | 0 |
| Fully recovered | 0 | 0 | 0 | 0 |
AFM, acute flaccid myelitis; IVIG, intravenous immunoglobulin; TM, transverse myelitis.